ATS Logo

The American Thoracic Society (ATS) is a 14,000 member educational and scientific society incorporated in the United States as a 501C(3) (tax-exempt) non-profit organization. The ATS was founded in 1905 by a group of tuberculosis hospital directors and has continued to be the major medical professional and scientific organization with an interest in tuberculosis. The focus of the ATS on tuberculosis is reflected by its leadership role in developing jointly with the U.S. Centers for Diseases Control and Prevention (CDC) guidelines for tuberculosis prevention, treatment and control that are used not only in the United States but in other parts of the world as well. In addition, the ATS publishes the American Journal of Respiratory and Critical Care Medicine, a highly respected and widely read scientific journal in which a wide range of tuberculosis research papers are published. The annual ATS International Conference, attracts approximately 15,000 attendees each year, is a major forum for the presentation of new information about tuberculosis and tuberculosis control as well as providing an arena for tuberculosis training and education.


FHI 360 Logo

FHI 360 is a global development organization with a rigorous, evidence-based approach. Our professional staff includes experts in health, nutrition, education, economic development, civil society, environment and research. FHI 360 operates from 60 offices with 4,400 staff in the U.S. and around the world. Our commitment to partnerships at every level and our multidisciplinary approach enable us to have lasting impact on the individuals, communities and countries we serve-improving lives for millions.


The Union Logo

The mission of the International Union Against Tuberculosis and Lung Disease (The Union) is to bring innovation, expertise, solutions and support to address health challenges in low- and middle-income populations. Founded in 1920, The Union today is both a non-profit institute with five scientific departments and several offices worldwide and a federation of more than 3,300 organisations and individuals who are committed to the same goals. Its scientific departments focus on tuberculosis, HIV, lung health and non-communicable diseases, tobacco control and research; and each engages in research, provides technical assistance and offers training and other capacity-building activities leading to health solutions for the poor. The Union has offices serving the Africa, Asia Pacific, Europe, Latin America, Middle East, North America and South-East Asia regions and provides direct technical assistance, training and management courses to 75 countries, conducts clinical trials, organizes international conferences and training courses, manages multiple large scale grants, and publishes the peer reviewed International Journal of Tuberculosis and Lung Disease



The Japan Anti-Tuberculosis Association (JATA), established in 1939 primarily for the control of tuberculosis in Japan, has expanded its mission over the years to contribute to the fight against TB in the world. With the Research Institute of Tuberculosis (RIT) as the academic center of the Association, JATA ‘s scope of activities include: (1) public awareness raising and community mobilization on TB and other related health problems;, (2) fundraising; (3) clinical services; (4) surveillance and research, both basic and applied; (5) reference for mycobacterial disease; (6) human resource development; and (7) international collaboration. JATA has been a member of the International Union Against Tuberculosis and Lung Diseases (IUATLD) since 1952. The RIT was designated as a WHO collaborating center in 1982. JATA is also a member of the Stop TB Partnership and participates in activities of working groups under Stop TB. JATA has carried out current and past projects in Afghanistan, Bangladesh, Cambodia, China, Indonesia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Solomon Islands, Thailand, Yemen, Kenya and Zambia.



KNCV Tuberculosis Foundation (KNCV) is one of the principal international non-profit organizations that is exclusively dedicated to and focused on fighting TB worldwide and to strengthening health systems against TB, globally and locally. It was founded in 1903. Its mission is the global elimination of TB through the development and implementation of effective, efficient and sustainable TB control strategies.

KNCV is a founding member of the international Stop TB Partnership, and is active on four fronts: policy and guidelines development, long term technical assistance/country support, epidemiological and operational support, and Health System Strengthening. KNCV provides technical assistance in TB control in almost 40 countries. It facilitates the exchange of knowledge and experience on TB control with countries and partner organizations.

KNCV builds on peoples’ own strengths, capacities and sense of responsibility, and focuses on enabling and improving the capacity of TB control programs and partners to deal with the TB epidemic.

KNCV works closely with many partners, at local, national and global levels, and in countries across Africa, Asia, Europe and Latin America. KNCV provides a full range of services to national TB control programs, local partners, international organizations and platforms involved in global policy development.

KNCV provides advice and support for:
• The detection and treatment of TB
• A programmatic approach to fighting drug-resistant TB
• Managing the risk of infection
• Improving laboratory capacity
• Integrating TB control into HIV/AIDS programs
• Strengthening health care systems
• Focusing on poor and vulnerable groups
• Mobilizing communities and civil society.


MSH Logo

Management Sciences for Health (MSH) is a non-profit international health organization composed of more than 2,000 people from over 73 nations. Our mission is to save lives and improve the health of the world’s poorest and most vulnerable people by closing the gap between knowledge and action in public health. Together with our partners, we are helping managers and leaders in developing countries to create stronger management systems that improve health services for the greatest health impact.

MSH builds management systems to improve tuberculosis (TB) detection, diagnosis, and treatment. We have experience supporting national TB programs in implementation and expansion of quality DOTS; strategic planning and advocacy for TB control; DOTS policy and strategy; TB program assessment; TB norms, guidelines, and service protocols; TB surveillance; quality assurance and performance improvement; supervision for TB control; TB infection control; multidrug resistant TB (MDR TB) treatment and control programs; planning, cost-analysis and financing; integrating packages of services; and monitoring and evaluation.

MSH also works with national TB programs to mobilize communities to prevent and control TB and reduce stigma and discrimination. We promote collaboration between TB and HIV/AIDS programs, strengthen laboratory systems, services, and networks, and work with partners to develop laboratory policies, strategies, and procedures. MSH improves management of human resources, TB lab system strengthening, and anti-TB drug management. We also provide technical assistance at national, regional, and local levels; capacity-building and training for TB programs and staff; tools and resources to facilitate program management and implementation; and operations research to improve TB program performance.


WHO Logo

The WHO Stop TB Department aims to guide the global response to the TB epidemic and facilitate partnerships; provide evidence-based norms, standards and policies; support Member States in adapting and adopting the Stop TB Strategy within strengthened health systems; measure global progress, monitor and assess national program performance, financing and impact; and, enable progress across the continuum of TB research, linked within a wider health research strategy.

The WHO Stop TB Strategy aims to achieve: universal access to quality diagnosis and patient-centred treatment; reduce the human suffering and socioeconomic burden associated with TB; protect vulnerable populations from TB, TB/HIV and drug-resistant TB; support development of new tools and enable their timely and effective use; and protect and promote human rights in TB prevention, care and control.

WHO staff at headquarters in Geneva, the six regional and numerous country offices have promoted the implementation and scale up of the Stop TB Strategy in a number of countries and developed solid expertise on technical assistance to TB programmes in high burden countries. WHO can bring this expertise to TB CARE I in order to rapidly expand the Stop TB Strategy scale-up and provide extensive technical assistance in countries supported by the coalition.


CDC Logo

Whilst the Centers for Disease Control and Prevention (CDC) are not a partner in the coalition, they provide technical insights to both TB CARE I and TB CARE II.